RxDoctor Payments Data

Stacey Bartell, MD

Family Medicine · South Lyon, MINPI 1669476933

Payments from drug & device makers

$193in general payments, 2019–2025

Across 12 payments — averaging $16.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$57
  • Boston Scientific$43
  • Bausch Health US, LLC$20
  • GSK$19
  • AbbVie$16
  • Circassia Inc.$14
  • plus $24 from 2 others

What the payments were for

  • Food & beverage$193100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk4$57
Boston Scientific2$43
Bausch Health US, LLC1$20
GSK1$19
AbbVie1$16
Circassia Inc.1$14
AstraZeneca1$13
Pfizer1$12

How this compares

$193 in reported general payments places this provider in the 40th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$14,436
Medicare patients
44
Services billed
210

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide44$49,504
EliquisApixaban17$25,019
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$18,545
Pantoprazole Sodium70$1,166
Levothyroxine Sodium100$1,125
Duloxetine Hcl21$1,056
Atorvastatin Calcium105$1,046
Venlafaxine Hcl ErVenlafaxine Hcl32$973
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen23$851
Gabapentin60$848
Albuterol Sulfate HfaAlbuterol Sulfate30$791
Bupropion XlBupropion Hcl30$773
Metformin Hcl68$672
Losartan Potassium54$631
Potassium Chloride18$606

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$12$25,01917 claims
GSKTrelegy Ellipta$19$18,54519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in South Lyon

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →